Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.930
0.00 (0.01%)
At close: Oct 11, 2024, 4:00 PM
0.940
+0.010 (1.04%)
After-hours: Oct 11, 2024, 6:56 PM EDT
Iterum Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Iterum Therapeutics stock has a target of 5.00, which predicts an increase of 437.63% from the current stock price of 0.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 10, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ITRM is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +437.63% | Sep 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +437.63% | Aug 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +545.16% | Jun 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +545.16% | May 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +545.16% | May 14, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.37M
EPS This Year
-1.13
from -2.96
EPS Next Year
-0.57
from -1.13
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 24.5M | 51.1M | ||
Avg | n/a | 12.4M | 26.7M | ||
Low | n/a | 911,400 | 3.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 312.6% | ||
Avg | - | - | 115.6% | ||
Low | - | - | -70.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.08 | -0.30 | - | ||
Avg | -1.13 | -0.57 | -0.33 | ||
Low | -1.17 | -0.80 | -0.63 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.